Haematological and Biochemical Effects of Etonogestrel Subdermal Implant (Implanon) in Ilorin Nigeria
Author(s) -
O R Balogun,
Abiodun S. Adeniran,
Adebayo A. Adewole
Publication year - 2016
Publication title -
international journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 1658-7774
pISSN - 1658-3639
DOI - 10.12816/0049656
Subject(s) - medicine , etonogestrel , aspartate transaminase , alanine transaminase , alkaline phosphatase , alanine aminotransferase , prospective cohort study , implant , surgery , population , family planning , biology , biochemistry , environmental health , research methodology , enzyme
OBJECTIVESTo evaluate the effect of etonogestrel subdermal implant (Implanon) on haematological and biochemical parameters of its users.METHODOLOGYA prospective observational study among healthy women using Implanon for contraception. The study site was the family planning clinic of the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Informed consent was obtained and participants were followed up for three years. Follow up parameters were haematological and biochemical evaluation at insertion (baseline), first and third years post-insertion. Statistical analysis was with SPSS-version 20.0; p value <0.05 was significant.RESULTS124 participants of age 20-44 years were included in the study. During the period of study, a progressive increase in the weight as well as in the level of alanine transaminase and systolic blood pressure was recorded. As compared to the baseline values, statistically significant difference in the mean values of systolic blood pressure (p<0.01), alanine transaminase (p<0.01) and weight (p=0.001) were recorded at the first year. Packed Cell Volume (p=0.001), weight (p=0.001), alanine transaminase (p=0.001) and alkaline phosphatase (p<0.05) were significant at the third year. Between the first and third year post-insertion, there was statistically significant difference in Packed Cell Volume (p=0.001), urea (p<0.05), aspartate (p=0.001) and alanine transaminase (p=0.001) and weight (p=0.001). However, there were no clinically detectable abnormalities or pregnancy during the study period.CONCLUSIONHaematological and biochemical parameters change with Implanon use but they were not significant to cause clinical sequelae. Implanon remains a safe long term contraceptive.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom